IVF USA Concierge - Peter18:22

Hello! I'm delighted to provide you with exclusive one-on-one consultation.
How can I assist you?

What is the process and cost of egg freezing?

Home service Medic video honor Contact us

Neglected male fertility: Only 3 out of 10 men are qualified!

2024-02-07 20:00:15,visits: 200



Recent data shows that the situation of a sperm storage bank in China is worrying, with only 2-3 out of every 10 sperm donors meeting the quality standards. Research data confirms that over the past 15 years, the sperm concentration of normal men has decreased by about 30%. These figures indicate a serious challenge to male fertility in China. International studies have also found that the quality of perm has been declining globally for nearly half a century.


The internationally recognized gold standard for assessing male fertility is the duration it takes for conception, known as the waiting time for pregnancy, during which the wife does not use contraception. WHO data shows that for regular couples, the chances of conception within 12 months of regular intercourse without contraception are about 85%, and within 24 months, about 93% to 95%. If pregnancy does not occur after trying for more than a year, the male's fertility is considered low.


Male fertility includes both sexual and reproductive capabilities. Sexual dysfunction and sperm abnormalities are the main causes of low male fertility. Sexual dysfunction can lead to obstacles in sperm transport, and as aging, not only does the spermatogenic function of the testes decline, but infections in the reproductive system can also affect sperm quality and the patency of the vas deferens.


Any factor or disease that interferes with these processes will affect male fertility. Sexual dysfunction and sperm abnormalities are the main causes, while diseases such as genetic mutations, chromosomal abnormalities, and couples carrying mutations of Mediterranean anemia genes may also affect fertility.


Dr. Nathan Zhang, an expert in the field of assisted reproduction and founder of IVF USA, has proposed a solution to chromosomal abnormalities. He points out that most miscarriages in women are due to chromosomal abnormalities. The third-generation IVF-PGT technology, also known as pre-implantation genetic diagnosis/screening (PGD/PGS) in the United States, analyzes the genetic material of embryos before implantation to diagnose abnormalities and select healthy embryos for transplantation, effectively preventing the transmission of genetic diseases.


In the process of reproduction, the role of men is equally crucial. Whether through natural conception or through IVF, male fertility directly affects the success of reproduction. For couples planning to solve fertility problems through IVF, the quality of male sperm is an important factor affecting the success rate. The quantity, vitality, morphology, and DNA integrity of sperm directly affect the quality of embryos and thus the success of pregnancy. IVF USA currently provides services such as egg freezing and IVF, as well as third-party assisted reproduction to those in need. Our services have expanded beyond the United States to include IVF and egg freezing in Japan, Thailand, Mexico, Taiwan, Hong Kong, and other regions, working closely with top IVF doctors worldwide. As the founder of IVF USA, Dr. Nathan Zhang has extensive professional knowledge and experience and is committed to providing high-quality medical services to every patient. IVF USA is dedicated to providing professional reproductive counseling services. If you have any questions about overseas IVF, feel free to consult our expert team, and we will be happy to assist you.

Previous:Independent women must not neglect women's health and take responsibility for themselves! IVF USA Dr. Nathan Zhang discusses IVF-PGT in the US and Thailand. Next:A Comprehensive Guide to Calculating the Due Date for IVF in the United States! Dr. Nathan Zhang from IVF USA Talks About IVF in the United States and Thailand
  • Copyright©1999-2016, sinamd.com All rights reserved. | ICP ID:沪ICP备16006508号-1
  • Shanghai ZhiTe Biotechnology Co., Ltd. All rights reserved. Phone: 400-648-3872

Shanghai Public Network Security No. 31011002004335